example 203 [WO2017058503A1]   Click here for help

GtoPdb Ligand ID: 12664

Compound class: Synthetic organic
Comment: This compound is claimed as an inhibitor of the histone lysine methyltransferase SUV39H2, in Oncotherapy Science's patent WO2017058503A1 [1]. SUV39H2 catalyses the addition of repressive methylation marks on histone 3 at lysine 9 (H3K9).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 85.88
Molecular weight 480.88
XLogP 2.3
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC1=CC(=C(C=C1C2=CN3C=CC(=CC3=N2)N4CCN(CC4)P(=O)(OC)OC)Cl)OC
Isomeric SMILES COC1=CC(OC)=C(C2=CN3C=CC(N4CCN(P(=O)(OC)OC)CC4)=CC3=N2)C=C1Cl
InChI InChI=1S/C21H26ClN4O5P/c1-28-19-13-20(29-2)17(22)12-16(19)18-14-25-6-5-15(11-21(25)23-18)24-7-9-26(10-8-24)32(27,30-3)31-4/h5-6,11-14H,7-10H2,1-4H3
InChI Key MSTKHNHJVJYJPY-UHFFFAOYSA-N
Bioactivity Comments
Example 203 reduces cell viability in a range of human cancer cell lines [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
SUV39H2 histone lysine methyltransferase Hs Inhibitor Inhibition 8.8 pIC50 - 1
pIC50 8.8 (IC50 1.77x10-9 M) [1]
Description: Inhibition of SUV39H2-mediated H3 histone peptide methylation using [3H]-SAM as the methyl donor